stockrow
Saturday 7 November 2026
Export GMRS’s income statement to Excel — free account
GMR Solutions Inc.
GMRS Healthcare Medical Care Facilities
12.42
0.09
−0.72%
Follow GMRS
Alert me
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
19.70 | 19.70 | — | 19.70 |
+1 more quarter Free account |
P/S ratio |
0.17 | 0.00 | — | 0.00 | |
P/FCF ratio |
5.14 | 0.00 | — | 0.00 | |
P/Operating CF |
10.94 | 4.98 | — | 4.98 | |
P/B ratio |
1.23 | 3.01 | — | 3.01 | |
Price to Tangible BV |
0.00 | 0.00 | — | 0.00 | |
EV/Sales |
0.88 | 0.00 | — | 0.00 | |
EV/EBITDA |
5.01 | 0.00 | — | 0.00 | |
EV/Operating CF |
11.56 | 0.00 | — | 0.00 | |
EV/FCF |
26.77 | 0.00 | — | 0.00 | |
Quick Ratio |
1.58 | 1.48 | 1.60 | — | |
Current Ratio |
2.01 | 1.87 | 2.00 | — | |
Net Debt/EBITDA |
29.94 | 15.81 | 0.00 | 0.00 | |
Debt/Assets |
60.48% | 69.69% | 68.44% | 0.00% | |
Debt/Equity |
5.69 | 24.05 | 25.08 | 0.00 | |
Asset Turnover |
1.55 | — | — | — | |
Operating CF/Net income |
(0.77) | 3.04 | — | 0.74 | |
Capex/Depreciation |
(0.91) | (0.82) | — | (0.76) | |
Interest Coverage |
0.74 | 2.63 | — | 2.22 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
62.04% | 52.83% | — | 51.50% | |
Intangible Assets out of Total Assets |
0.45 | 0.46 | 0.45 | 0.00 | |
Share Based Compensation of Revenue |
8.90% | (0.01%) | — | 0.06% | |
Graham Net Nets |
(4.76) | (8.01) | — | (8.01) | |
Graham Number |
14.91 | 0.00 | — | 0.00 | |
Earnings Yield |
5.08% | 5.08% | — | 5.08% | |
Free Cash Flow Yield |
19.44% | 0.00% | — | 0.00% | |
Revenue per Share |
23.78 | 31.80 | — | 31.65 | |
Operating CF per Share |
1.41 | 2.81 | — | 0.64 | |
Capex per Share |
(1.16) | (1.40) | — | (1.28) | |
Free Cash Flow per Share |
0.26 | 1.41 | — | (0.64) | |
Cash per Share |
6.70 | 9.30 | 0.00 | 0.00 | |
Shareholders Equity per Share |
12.59 | 4.64 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
12.59 | 4.64 | 0.00 | 0.00 | |
Free Cash Flow |
16.06 | 64.61 | — | (29.18) | |
Working Capital |
1,017.13 | 926.85 | 1,067.65 | — | |
Capital Expenditures |
(72.53) | (64.14) | — | (58.51) | |
Net Current Asset Value |
(4,617.02) | (5,133.14) | (5,145.81) | 0.00 | |
EV/EBIT |
7.26 | 0.00 | — | 0.00 | |
Capex to Sales |
0.05 | 0.04 | — | 0.04 | |
Price to Operating Income |
1.40 | 0.00 | — | 0.00 | |
| Other line items | |||||
Average Assets |
3,714.63 | — | — | — |
Columns are period end dates · fundamentals updated 26 Oct 2026